After a year of record-low drug approvals, 2023 is shaping up to be a rebound. 📈 To date, the FDA has approved “35 new molecular entities and new therapeutic biological products, plus 10 vaccines, allergenic products, and cell and gene therapies”. https://bit.ly/3Ldtvf0